Bitcoin set for a rebound that could stretch toward $100000, BTIG says
Medpace Holdings Inc (NASDAQ:MEDP) Executive Vice President of Operations, Susan E. Burwig, sold 18,000 shares of common stock on November 11, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a price of $605.0, for a total transaction value of $10.89 million. The sale comes as Medpace trades near its 52-week high of $625, having delivered impressive returns of 92% over the past six months according to InvestingPro data.
Following the transaction, Burwig directly owns 47,500 shares of Medpace Holdings. The sale was executed pursuant to a limit order placed by Burwig during an open window period. While executives sell, InvestingPro analysis shows management has been aggressively buying back shares, despite the stock currently trading above its Fair Value. With a P/E ratio of 42.2 and excellent financial health scores, Medpace offers comprehensive Pro Research Reports among 1,400+ US equities covered on the platform.
In other recent news, Medpace Holdings Inc. reported its third-quarter 2025 earnings, which exceeded market expectations. The company posted an earnings per share (EPS) of $3.86, surpassing the forecasted $3.53. Revenue also outperformed projections, reaching $659.9 million compared to the anticipated $640.99 million. Following these strong financial results, Truist Securities raised its price target for Medpace to $555 from $436, while maintaining a Hold rating. The price target adjustment came after discussions between Truist Securities and Medpace management regarding performance metrics and future outlook. These developments highlight significant investor interest in Medpace’s recent performance and future potential.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.